Ciglitazone is a thiazolidinedione that exhibits antihypertensive, anticancer, and anti-diabetic activities. Ciglitazone acts as an agonist at PPAR? receptors, decreasing insulin levels, VEGF production, and blood pressure. In cellular models of stomach cancer, ciglitazone induces G1 phase cell…

An antidiabetic drug and selective PPARγ agonist (EC₅₀ = 3.0 µM); active in vivo as an anti-hyperglycemic agent the ob/ob mouse model.